InvestorsHub Logo
Post# of 252455
Next 10
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 233988

Friday, 10/30/2020 9:31:40 AM

Friday, October 30, 2020 9:31:40 AM

Post# of 252455
ABBV 3Q20 Mavyret sales=$414M, +10% QoQ, -41% YoY:

As reported by GILD yesterday (#msg-159176251), COVID-19 continued to impede new-HCV-patient starts during 3Q20.

The 3Q20 Mavyret breakdown was: $185M US; $214M ex-US.

2020 Mavyret sales for the first nine months are now $1.34B.

PR:
https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-third-quarter-2020-financial-results

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.